- Home
- SCS vs ATRC Comparison
SCS vs ATRC Comparison
Compare SCS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCS
- ATRC
- Stock Information
- Founded
- SCS 1912
- ATRC 2000
- Country
- SCS United States
- ATRC United States
- Employees
- SCS N/A
- ATRC N/A
- Industry
- SCS Office Equipment/Supplies/Services
- ATRC Medical/Dental Instruments
- Sector
- SCS Consumer Discretionary
- ATRC Health Care
- Exchange
- SCS Nasdaq
- ATRC Nasdaq
- Market Cap
- SCS 1.8B
- ATRC 1.7B
- IPO Year
- SCS 1998
- ATRC 2005
- Fundamental
- Price
- SCS $16.88
- ATRC $34.63
- Analyst Decision
- SCS Buy
- ATRC Strong Buy
- Analyst Count
- SCS 1
- ATRC 10
- Target Price
- SCS $16.00
- ATRC $49.60
- AVG Volume (30 Days)
- SCS 1.7M
- ATRC 416.8K
- Earning Date
- SCS 09-24-2025
- ATRC 10-28-2025
- Dividend Yield
- SCS 2.37%
- ATRC N/A
- EPS Growth
- SCS 37.12
- ATRC N/A
- EPS
- SCS 1.04
- ATRC N/A
- Revenue
- SCS $3,217,700,000.00
- ATRC $499,946,000.00
- Revenue This Year
- SCS $4.30
- ATRC $16.32
- Revenue Next Year
- SCS $3.51
- ATRC $12.37
- P/E Ratio
- SCS $16.22
- ATRC N/A
- Revenue Growth
- SCS 2.64
- ATRC 16.28
- 52 Week Low
- SCS $9.32
- ATRC $25.57
- 52 Week High
- SCS $17.25
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- SCS 66.29
- ATRC 45.54
- Support Level
- SCS $16.68
- ATRC $34.57
- Resistance Level
- SCS $17.02
- ATRC $38.08
- Average True Range (ATR)
- SCS 0.25
- ATRC 1.41
- MACD
- SCS -0.18
- ATRC -0.28
- Stochastic Oscillator
- SCS 61.46
- ATRC 6.57
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.